126
Participants
Start Date
October 31, 2007
Primary Completion Date
July 31, 2009
Study Completion Date
September 30, 2009
Recombinant Human GCSF (Shantha Biotechnics Limited)
Dose: 300 mcg/day administered subcutaneous/intravenous/continuous subcutaneous infusion for a minimum of 7 days and for a maximum of 14 days or till Neutrophil count of 10,000/mm3 is reached whichever is earlier
Neupogen
Dose: 300mcg/day administered subcutaneous/intravenous/continuous subcutaneous infusion for a minimum of 7 days and for a maximum of 14 days or till Neutrophil count of 10,000/mm3 is reached whichever is earlier
SMS Medical College and Hospital, Jaipur
Vedanta Institute of Medical Sciences, Ahmedabad
Seth Ramdas Shah Memorial Hospital, Pune
Indo American Cancer Institute and Research Centre, Hyderabad
Nizam's Institute of Medical Sciences, Hyderabad
Lakeshore Hospital and Research Center, Kochi
Regional Cancer Centre, Trivandrum
Shantha Biotechnics Limited
INDUSTRY